Clinical Trial Update: Infliximab Biosimilar in Takayasu's Arteritis

View source ↗

Summary

Clinical trial update about an infliximab biosimilar being studied for Takayasu arteritis. The current trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Takayasu Arteritis

Drugs mentioned

• Infliximab biosimilar

Snippet

Sponsor: Ospedale San Raffaele | Conditions: Takayasu Arteritis | Status: UNKNOWN